BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15645262)

  • 21. Prion diseases and the immune system.
    Aucouturier P; Carp RI; Carnaud C; Wisniewski T
    Clin Immunol; 2000 Aug; 96(2):79-85. PubMed ID: 10900153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of cerebral neurodegeneration in prion diseases.
    Tatzelt J; Schätzl HM
    FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
    Tayebi M; Hawke S
    Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in sympathetic activity in prion neuroinvasion.
    Bondiolotti G; Rossoni G; Puricelli M; Formentin E; Lucchini B; Poli G; Ponti W; Bareggi SR
    Neurobiol Dis; 2010 Jan; 37(1):114-7. PubMed ID: 19804827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible role for Ca2+ in the pathophysiology of the prion protein?
    Peggion C; Bertoli A; Sorgato MC
    Biofactors; 2011; 37(3):241-9. PubMed ID: 21698700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [When prions use the systems of communication between the immune system and the peripheral nervous system].
    Dorban G; Antoine N; Defaweux V
    Med Sci (Paris); 2010; 26(6-7):610-4. PubMed ID: 20619163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular prion protein mediates toxic signaling of amyloid beta.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Neurodegener Dis; 2012; 10(1-4):298-300. PubMed ID: 22156337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prions and prion diseases.
    Beekes M
    FEBS J; 2007 Feb; 274(3):575. PubMed ID: 17288546
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination against prion diseases.
    Kalinke U; Bach P; König M; Buchholz CJ
    Discov Med; 2006 Feb; 6(31):29-34. PubMed ID: 17234125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prion diseases: what is the role of dendritic cells in the pathogenesis of transmissible prion diseases?].
    Bachy V; Aucouturier P
    Med Sci (Paris); 2010; 26(6-7):615-20. PubMed ID: 20619164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The chronopathology of prion encephalopathies].
    Menéndez-González M; García-Fernández C; Suárez-San Martín E; Antón-González C; Blázquez-Menes B
    Rev Neurol; 2004 Nov 16-30; 39(10):962-5. PubMed ID: 15573315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of prion pathogenesis.
    Aguzzi A; Sigurdson C; Heikenwaelder M
    Annu Rev Pathol; 2008; 3():11-40. PubMed ID: 18233951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological role of the cellular prion protein.
    Zomosa-Signoret V; Arnaud JD; Fontes P; Alvarez-Martinez MT; Liautard JP
    Vet Res; 2008; 39(4):9. PubMed ID: 18073096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglia in Prion Diseases: Angels or Demons?
    Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS pathogenesis of prion diseases.
    Brandner S
    Br Med Bull; 2003; 66():131-9. PubMed ID: 14522855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.